No higher resolution available.
This file is from a shared repository and may be used by other projects.
The description on its file description page there is shown below.
License
Attribution-NonCommercial 3.0 Unported (CC BY-NC 3.0)
Summary
Author:Sadeghi S, Olevsky O, Hurvitz SA ,Division of Hematology & Oncology, David Geffen School of Medicine, University of California(Openi/National Library of Medicine) Source:https://openi.nlm.nih.gov/detailedresult?img=PMC4207068_pgpm-7-329Fig1&query=Trastuzumab%20emtansine&it=xg&req=4&npos=3 Description:f1-pgpm-7-329: Structure of trastuzumab emtansine and mechanisms of action.Notes: On binding of trastuzumab emtansine (T-DM1) to human growth factor receptor 2 (HER2), T-DM1 is internalized and undergoes lysosomal degradation. This results in the release of DM1, which binds to tubulin, resulting in the suppression of microtubule dynamic instability and prevention of microtubule polymerization. T-DM1 has also been shown to retain mechanisms of action of trastuzumab, including disruption of HER2 signal transduction and antibody-dependent cellular cytotoxicity (ADCC). Reprinted by permission from the American Association for Cancer Research: LoRusso PM, Weiss D, Guardino E, Girish S, Sliwkowski MX. Trastuzumab emtansine: a unique antibody-drug conjugate in development for human epidermal growth factor receptor 2-positive cancer. Clin Cancer Res. 2011; 17(20):6437–6447. DOI: 10.1158/1078-0432.CCR-11-0762.41Abbreviation: MCC, 4-[N-maleimidomethyl] cyclohexane-1-carboxylate.
File history
Click on a date/time to view the file as it appeared at that time.
| Date/Time | Thumbnail | Dimensions | User | Comment |
current | 00:11, 28 December 2021 | | 512 × 497 (346 KB) | Ozzie10aaaa | Author:Sadeghi S, Olevsky O, Hurvitz SA ,Division of Hematology & Oncology, David Geffen School of Medicine, University of California(Openi/National Library of Medicine) Source:https://openi.nlm.nih.gov/detailedresult?img=PMC4207068_pgpm-7-329Fig1&query=Trastuzumab%20emtansine&it=xg&req=4&npos=3 Description:f1-pgpm-7-329: Structure of trastuzumab emtansine and mechanisms of action.Notes: On binding of trastuzumab emtansine (T-DM1) to human growth factor receptor 2 (HER2), T-DM1 is internalize... |
File usage
The following page uses this file: